CVS Health Reports Second Quarter Results; Diversified Assets Deliver Strong Enterprise Results

Go back to CVS Health Reports Second Quarter Results; Diversified Assets Deliver Strong Enterprise Results

CVS Health (CVS) Tops Q2 EPS by 72c, Offers FY Guidance

August 5, 2020 6:35 AM EDT

CVS Health (NYSE: CVS) reported Q2 EPS of $2.64, $0.72 better than the analyst estimate of $1.92. Revenue for the quarter came in at $65.3 billion versus the consensus estimate of $64.18 billion.

GUIDANCE:

CVS Health sees FY2020 EPS of $7.14-$7.27, versus the consensus of... More